Prevalence of Carbapenem Resistant Enterobactericeae (CRE) in a Tertiary Care Hospital

Dr. Parismita Sahoo

Abstract: Enterobacteriaceae family is an important cause of urinary tract infections (UTIs), bloodstream infections, hospital acquired pneumonias. The prevalence of ESBLs producing Enterobacteriaceae made carbapenem a preferred drug in the treatment of MDR Enterobacteriaceae. But indiscriminate use of carbapenem to tackle the ESBL producing organism leads to carbapenem resistance in healthcare and community settings. Identifying carbapenem resistant organisms and implementing measures to prevent the spread is need of the hour.

Keywords: Carbapenem Resistant Enterobactericeae, CRE

Edition: Volume 13 Issue 4, April 2024,

Pages: 766 - 769

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait

Prevalence of Carbapenem Resistant Enterobactericeae (CRE) in a Tertiary Care Hospital

Similar Articles with Keyword 'CRE'

Isolation of Common Nosocomialpathogens from Gate Pass Used in Aminu Kano Teaching Hospital and Bayero University Kano, Nigeria

Comparative Studies on the Enhanced Production of Heparinase by Physical and Chemical Mutagen